Trials / Completed
CompletedNCT05357976
The Effects of Body Mass Index on Thoracic Paravertebral Block Analgesia
The Effects of Body Mass Index on Thoracic Paravertebral Block Analgesia Treatment in Patients Undergoing Thoracoscopic Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Ankara City Hospital Bilkent · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Obesity has become one of the world's leading health problems. It is known that obesity causes many diseases and negatively affects the quality of life. For this reason, many conditions that are thought to be effective in obesity and concern the quality of life of patients have been scientifically researched and continue to be investigated. One of them is postoperative pain. Although there are studies stating that there is no relationship between body mass index (BMI) and postoperative pain, when the literature data is examined, it is thought that obesity is a risk factor for postoperative pain and changes pain sensitivity and analgesic needs of patients. There are also studies in the literature stating that the level of postoperative pain increases in parallel with each unit increase in BMI. After thoracic surgery, many analgesic methods have been suggested, including thoracic epidural analgesia (TEA), thoracic paravertebral block (TPVB), intercostal nerve blocks (ICSB), erector spina plane block (ESPB), serratus anterior plane block (SAPB). This study will compare the effects of BMI on postoperative pain in patients undergoing TPVB for postoperative analgesia and thoracoscopic surgery.
Conditions
- Pain, Postoperative
- Acute Pain
- Thoracic Paravertebral Block
- Body Mass Index
- Thoracic Surgery, Video-Assisted
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Thoracic Paravertebral Block | Thoracic paravertebral block will be applied to the patients under real-time ultrasound guidance. |
Timeline
- Start date
- 2022-04-25
- Primary completion
- 2023-05-01
- Completion
- 2023-05-13
- First posted
- 2022-05-03
- Last updated
- 2023-05-16
Locations
2 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05357976. Inclusion in this directory is not an endorsement.